Special Course of Food and Health Science, Department of Bioscience Graduate School of Agriculture, Ehime University, Matsuyama, Ehime, Japan.
Institute of Community Life Sciences Co., Ltd, Matsuyama, Ehime, Japan.
Aging Clin Exp Res. 2021 Nov;33(11):3099-3108. doi: 10.1007/s40520-020-01513-3. Epub 2020 Mar 11.
In this study, the effects of licorice flavonoid oil (LFO) supplementation on mobility functions were evaluated in middle-aged and older women who underwent daily physical exercise.
The 73 women aged 59-85 years (71.2 ± 5.2 years) were randomly assigned to the LFO group (n = 37) or the placebo group (n = 36). For 16 weeks, the LFO group consumed a daily capsule containing 300 mg of LFO, while the placebo group consumed a placebo capsule. All participants were instructed to complete a strength training program during the 16 weeks and to increase their daily step count by 1000. 10-m walking speed (with/no obstruction), one-leg standing time with eyes open, handgrip strength, isometric knee extension strength, and body composition were evaluated at baseline and every eight weeks.
In the 10-m walking speeds (with/no obstruction), LFO supplementation did not show significant improvements. One-leg standing time was significantly prolonged with LFO intake (LFO: baseline 73.9 s vs 16 weeks 93.5, placebo: baseline 82.8 vs 16 weeks 87.1, p = 0.03). In addition, a significant decrease in BMI and body fat percentage with LFO was found (p = 0.01, p = 0.03, respectively).
Since a lower BMI corresponds to a lighter physical load on the lower limb, in addition, since LFO might improve skeletal muscle function by antioxidant activity, participants could stand longer and body balance control was improved.
LFO supplementation improved body balance control and may contribute to fall prevention in healthy middle-aged and older women having daily physical exercise.
UMIN Clinical Trial Registry No. 000029712.
本研究旨在评估中老年人在进行日常体育锻炼时补充甘草黄酮油(LFO)对运动功能的影响。
将 73 名年龄在 59-85 岁(71.2±5.2 岁)的女性随机分为 LFO 组(n=37)或安慰剂组(n=36)。16 周内,LFO 组每天服用 300mg LFO 胶囊,安慰剂组服用安慰剂胶囊。所有参与者均被要求在 16 周内完成力量训练计划,并将每天的步数增加 1000 步。在基线和每 8 周评估 10m 步行速度(有/无障碍物)、单腿站立时间(睁眼)、握力、等长膝关节伸展力量和身体成分。
在 10m 步行速度(有/无障碍物)方面,LFO 补充剂没有显示出显著的改善。LFO 摄入可显著延长单腿站立时间(LFO:基线 73.9s vs 16 周 93.5s,安慰剂:基线 82.8s vs 16 周 87.1s,p=0.03)。此外,LFO 还可显著降低 BMI 和体脂百分比(p=0.01,p=0.03)。
由于 BMI 较低意味着下肢的物理负荷较轻,此外,由于 LFO 可能通过抗氧化活性改善骨骼肌功能,因此参与者可以站立更长时间,身体平衡控制得到改善。
LFO 补充剂可改善身体平衡控制,有助于预防有日常体育锻炼的健康中老年人跌倒。
UMIN 临床试验注册编号 000029712。